| Ytd | 18.86% | |
| 1y | 103.92% |
| Open | 4.14 | Prev Close | 4.14 | Low | 3.99 | High | 4.32 | Mkt Cap | 175.18M |
| Vol | 87.89K | Avg Vol | 139.97K | EPS | -0.22 | P/E | -18.91 | Forward P/E | -3.39 |
| Beta | 1.39 | Short Ratio | 5.49 | Inst. Own | 40.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.23 | 200-d Avg | 3.84 | 1yr Est | 2.83 |
APYX News
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.07) per share which beat the analyst con
Apyx Medical (NASDAQ:APYX) affirms FY2026 sales outlook from $59.000 million-$60.000 million to $59.
Wall Street analysts changed outlook on top stocks. To see all changes, visit the analyst ratings pa
HC Wainwright & Co. analyst Yi Chen initiates coverage on Apyx Medical (NASDAQ:APYX) with a B
https://www.sec.gov/ix?doc=/Archives/edgar/data/719135/000149315226029081/form8-k.htm
In this study, 22 patients received a single treatment session combining these modalities to address
The study evaluated patient-reported outcomes following liposuction with and without helium plasma r
Apyx Medical (NASDAQ:APYX) raises FY2026 sales outlook from $57.500 million-$58.500 million to $59.0
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst con
Craig-Hallum analyst Matthew Hewitt maintains Apyx Medical (NASDAQ:APYX) with a Buy and raises th
Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised pri
Apyx Medical (NASDAQ:APYX) sees FY2026 sales of $57.500 million-$58.500 million vs $55.480 million a
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.03) per share which beat the analyst con
